Medicrea Launches UNiD™ HUB Proprietary Surgical Planning Through Machine Learning at NASS 2017
October 24 2017 - 2:30AM
Business Wire
The Medicrea Group (Euronext Growth Paris: FR0004178572 -
ALMED), pioneering the convergence of healthcare IT and
next-generation, outcome-centered device design and manufacturing
with UNiD™ ASI technology, announced today that the Company will
launch their UNiD™ HUB software at the 32nd Annual Meeting of the
North American Spine Society (NASS), held October 25-28, 2017 in
Orlando, Florida, with UNiD™ LAB biomedical engineers on-hand to
demonstrate the software’s proprietary data-driven surgical
planning and workflow functionalities.
Denys Sournac, President and Chief Executive Officer, stated.
“We are pleased to launch our UNiD™ HUB to the U.S. spine surgeon
community at NASS 2017. In developing an industry-first software
platform that fully integrates FDA-cleared adaptive and intelligent
surgical planning through machine learning, we are uniquely able to
harness the power of our exclusive and growing data set linked to
the more than 1,800 UNiD™ ASI surgeries performed to date to drive
improved outcomes and efficiencies in spine surgery, as confirmed
by our recently released clinical results.”
The user-friendly UNiD™ HUB, a web-based portal, also available
as a mobile and tablet application, will manage the complete
surgeon workflow for the Company’s UNiD™ ASI (Adaptive Spine
Intelligence) technology and will become the surgeon’s primary
touchpoint for collaboration with Medicrea’s UNiD™ LAB biomedical
engineers to develop predictive, data-driven case plan strategies
and to materialize personalized UNiD™ TEK, patient-specific
implants, before surgery.
Surgeons will be able to instantly view metrics on their
upcoming and previous UNiD™ ASI cases through the software’s
dashboard upon login, with notifications alerting them of plan
completion, pending actions, and tracking for personalized implant
delivery. They are also able to manage their full case database
from within the UNiD™ HUB directly with specialized search,
organization and favoriting functionalities as well as perform
powerful data visualizations and analytical reporting based on
their selections.
Medicrea will showcase the UNiD™ HUB software alongside its
UNiD™ ASI systems technology in Medicrea Booth #513 at the NASS
Annual Meeting. The technology will also be presented by Dr. Paul
McAfee, of the University of Maryland St. Joseph Medical Center, at
the NASS Solution Showcase Theater on the Exhibit Hall Floor from
12:00 to 12:30pm on Thursday, October 26.
On the evening of Thursday, October 26, Dr. Paul McAfee will be
joined by Dr. Christopher Kleck, of University Colorado Hospital,
and Thomas Mosnier, PhD, Chief Scientific Officer at Medicrea, to
host an interactive forum on Adaptive Spine Intelligence and its
Influence on Spinal Treatment Options at the Hyatt Regency Orlando.
To meet with Medicrea at NASS 2017 or express your interest in
attending the interactive forum, please contact Gordon Fu,
gfu@medicrea.com.
About Medicrea (www.Medicrea.com)
Through the lens of predictive medicine, Medicrea leads the
design, integrated manufacture, and distribution of 30+ FDA
approved spinal implant technologies that have been utilized in
over 150,000 spinal surgeries to date. By leveraging its
proprietary software analysis tools with big data and machine
learning technologies and supported by an expansive collection of
clinical and scientific data, Medicrea is well-placed to streamline
the efficiency of spinal care, reduce procedural complications and
limit time spent in the operating room.
Operating in a $10 billion marketplace, Medicrea is a Small and
Medium sized Enterprise (SME) with 175 employees worldwide, which
includes 50 who are based in the U.S. The Company has an
ultra-modern manufacturing facility in Lyon, France housing the
development and production of 3D-printed titanium patient-specific
implants.
For further information, please visit: Medicrea.com.
Connect with Medicrea:
FACEBOOK | INSTAGRAM | TWITTER | WEBSITE |
YOUTUBE
Medicrea is listed onEURONEXT Growth
ParisISIN: FR 0004178572Ticker: ALMEDLEI:
969500BR1CPTYMTJBA37
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171023006543/en/
MedicreaDenys SournacFounder, Chairman and
CEOdsournac@Medicrea.comorFabrice Kilfiger, +33 (0)4 72 01 87
87Chief Financial Officerfkilfiger@Medicrea.com